Literature DB >> 21372120

Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis.

A K Hedström1, M Bäärnhielm, T Olsson, L Alfredsson.   

Abstract

BACKGROUND: Tobacco smoking has consistently been associated with increased risk for multiple sclerosis. However, data has been inconsistent regarding the influence of passive smoking.
OBJECTIVE: The aim was to estimate the influence of passive smoking on the risk for multiple sclerosis.
METHODS: A population-based case-control study using incident cases of multiple sclerosis was performed in Sweden, and the study population was restricted to subjects who had never smoked (695 cases, 1635 controls). The incidence of multiple sclerosis among never-smokers who had been exposed to passive smoking was compared with that of never-smokers who had never been exposed by calculating the odds ratio with a 95% confidence interval employing logistic regression.
RESULTS: The risk for multiple sclerosis was increased among never-smokers who had been exposed to passive smoking (OR 1.3, 95% CI 1.1-1.6) compared to never-smokers who had never been exposed. The risk increased with increasing duration of exposure (p = 0.003).
CONCLUSIONS: Exposure to environmental tobacco smoke is associated with an increased risk for multiple sclerosis. Since smoking, but not usage of oral tobacco in the form of moist snuff, is associated with increased risk for multiple sclerosis, we consider that the critical effects of passive smoking may be the result of irritations in the lungs. Hence, further studies would be valuable in order to clarify whether other forms of lung irritation, such as air pollution, contribute to the triggering of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372120     DOI: 10.1177/1352458511399610

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  29 in total

1.  Smoking: effects on multiple sclerosis susceptibility and disease progression.

Authors:  Dean M Wingerchuk
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

3.  Protective environmental factors for neuromyelitis optica.

Authors:  Jennifer Graves; Siri Grandhe; Kelley Weinfurtner; Lauren Krupp; Anita Belman; Tanuja Chitnis; Jayne Ness; Bianca Weinstock-Guttman; Mark Gorman; Marc Patterson; Moses Rodriguez; Tim Lotze; Gregory Aaen; Ellen M Mowry; John W Rose; Timothy Simmons; T Charles Casper; Judith James; Emmanuelle Waubant
Journal:  Neurology       Date:  2014-10-22       Impact factor: 9.910

Review 4.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

5.  Association of smoking with risk of multiple sclerosis: a population-based study.

Authors:  Sreeram V Ramagopalan; Joshua D Lee; Irene M Yee; Colleen Guimond; Anthony L Traboulsee; George C Ebers; A Dessa Sadovnick
Journal:  J Neurol       Date:  2013-03-02       Impact factor: 4.849

6.  Smoking and multiple sclerosis: evidence for latitudinal and temporal variation.

Authors:  C O'Gorman; S A Broadley
Journal:  J Neurol       Date:  2014-06-13       Impact factor: 4.849

7.  Influence of cigarette smoking on white matter in patients with clinically isolated syndrome as detected by diffusion tensor imaging.

Authors:  Gamze Durhan; Sevda Diker; Arzu Ceylan Has; Jale Karakaya; Asli Tuncer Kurne; Kader Karli Oguz
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

8.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 9.  Modifiable comorbidities and disability in multiple sclerosis.

Authors:  Shannon Overs; Christina M Hughes; Jodie K Haselkorn; Aaron P Turner
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

10.  Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains.

Authors:  Jimmy L Huynh; Paras Garg; Tin Htwe Thin; Seungyeul Yoo; Ranjan Dutta; Bruce D Trapp; Vahram Haroutunian; Jun Zhu; Michael J Donovan; Andrew J Sharp; Patrizia Casaccia
Journal:  Nat Neurosci       Date:  2013-11-24       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.